Yishan Ye

23PUBLICATIONS
48CO-AUTHORS
Gene and molecular therapyCardiology (incl. cardiovascular diseases)Respiratory diseasesHaematological tumoursCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jun 26, 2026
Peri-transplant TP53 molecular MRD as a prognostic biomarker of relapse in TP53-mutated AML/MDS undergoing allogeneic HCT.

|Jun 11, 2026
Chronic graft-versus-host disease.

|Mar 06, 2026
Therapy of high-risk myelodysplastic syndromes.

Yishan Ye, Eolia Brissot, Ali Bazarbachi

|Jul 14, 2025
Impact of TP53 variants and germline mutations on allogeneic stem cell transplantation outcomes in acute myeloid leukemia and myelodysplastic neoplasms.

Yeqian Zhao, Weijie Cao, Jimin Shi

|Jul 12, 2025
Superior GVHD-Free, Relapse-Free Survival for Haploidentical Transplant With PTCy Than Matched Unrelated Donor for AML Patients Transplanted in Second Complete Remission: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Yishan Ye, Myriam Labopin, Ibrahim Yakoub-Agha

|Jul 04, 2025
Machine learning-based prediction of G-CSF-induced hematopoietic stem cell mobilization outcomes in healthy volunteers.

Ce Shi, Xiangjun Zeng, Jimei Ge

Pageof 4

Frequent Collaborators

11 joint publications

He Huang

7 joint publications

Yanmin Zhao

7 joint publications

Yi Luo

7 joint publications

Ali Bazarbachi